STOCK TITAN

OneMedNet Corp Warrant 8-K Filings

ONMDW NASDAQ

Every 8-K that OneMedNet Corp Warrant (ONMDW) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 8-K covers material events a company has to report between its quarterly reports, so if you follow ONMDW and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ONMDW filings page.

Rhea-AI Summary

OneMedNet Corporation has set September 18, 2026 as the date of its 2026 Annual Meeting of Stockholders, with August 11, 2026 as the record date for stockholders entitled to notice of and to vote at the meeting.

Stockholder proposals for inclusion in the company’s proxy materials, other stockholder proposals, and nominations of director candidates must all be received by the Secretary of the company no later than August 5, 2026, in accordance with SEC Rule 14a-8, SEC Rule 14a-19 for any director election contest, and the company’s Bylaws.

Rhea-AI Summary

OneMedNet Corporation entered into a Standby Equity Purchase Agreement with YA II PN, Ltd. that allows the company, at its option, to sell up to $25 million of common stock over time. Sales can begin only after a resale registration statement for these shares becomes effective.

The agreement runs for 36 months. Each advance is limited to the greater of 500,000 shares and 100% of the stock’s five-day average trading volume, and is priced at 97% of the Market Price as defined in the agreement. Yorkville cannot exceed 4.99% beneficial ownership and, absent shareholder approval, total issuances are capped at 11,386,834 shares, which the company states is 19.99% of the 56,952,652 shares outstanding as of June 30, 2026.

Rhea-AI Summary

OneMedNet Corporation reported that Nasdaq has notified the company its common stock no longer meets the $1.00 minimum bid price requirement, after trading below that level for 30 consecutive business days. The company has 180 days, until October 12, 2026, to regain compliance by having its share price at or above $1.00 for at least ten consecutive business days. If it still does not comply, OneMedNet may qualify for an additional 180-day period if it meets other Nasdaq Capital Market listing standards and commits to a plan that may include a reverse stock split. The company notes there is no assurance it will regain or maintain compliance, and failure to do so could result in Nasdaq delisting its shares.